Quantcast

Tag Archives: pharmaceutical litigation

Pfizer must pay $142M over Neurontin marketing

Drug maker Pfizer violated the Racketeer Influenced and Corrupt Organizations Act by engaging in a fraudulent marketing scheme promoting the epilepsy drug Neurontin for “off-label” uses, the 1st U.S. Circuit Court of Appeals has ruled in affirming judgment.

Read More »

Benchmarks: Oops! Mom gets vitamins instead of birth control pills

A Wisconsin woman noticed that the birth control pills she received from her family health clinic in February 2009 looked a little different. A positive pregnancy test ten weeks later removed any doubt that she had been given prenatal vitamins ...

Read More »